Minimally Invasive Procedure Offers at Least 12 Months of Pain Relief for Lower Back Pain

Doesn’t Require General Anesthesia, Large Incisions, or Extended Recovery Time

Translate to Spanish or other 102 languages!

A study out of the University of Florida shows that a minimally invasive procedure, known as mild®, provides pain relief and improved physical function for at least a year in patients suffering from lumbar spinal stenosis (LSS), a common cause of lower back pain in older adults. Image for illustration purposes
A study out of the University of Florida shows that a minimally invasive procedure, known as mild®, provides pain relief and improved physical function for at least a year in patients suffering from lumbar spinal stenosis (LSS), a common cause of lower back pain in older adults. Image for illustration purposes
- Advertisement -

By  American Society of Regional Anesthesia and Pain Medicine (ASRA)

Newswise — A study out of the University of Florida shows that a minimally invasive procedure, known as mild®, provides pain relief and improved physical function for at least a year in patients suffering from lumbar spinal stenosis (LSS), a common cause of lower back pain in older adults.

The study followed 136 patients between the ages of 16 and 89 who underwent the mild® procedure, which is designed to reduce pressure on the spine by removing part of a thickened ligament. Unlike traditional spinal surgery, mild® doesn’t require general anesthesia, large incisions, or extended recovery time, making it a safer option for many older patients.

- Advertisement -

Patient-reported pain levels dropped dramatically within the first month after the procedure, with average pain scores reduced by 30 mm on a visual analogue scale. These improvements were both statistically and clinically significant. Although the pain relief lessened over time, the 12-month follow-up still showed marked improvement compared to baseline levels. In addition, more than 65% of patients also reported better physical function throughout the study, without any decrease in mobility or quality of life.

These findings could be significant for older adults suffering from lumbar stenosis, as the procedure could provide meaningful relief without the risks associated with traditional surgery. The study showed that the procedure improves pain and function over the long term, improving patients’ quality of life.

LSS affects more than 200,000 people in the United States and is a common reason for people to seek spinal surgery. Minimally invasive techniques can help patients avoid more invasive procedures and their associated complications.

Aaran Varatharajan, MD, will present the results on November 22 at 10:30 am PT during the ASRA Pain Medicine 23rd Annual Pain Medicine Meeting at Caesars Palace in Las Vegas, NV. The abstract, “Outcomes of the Minimally Invasive Lumbar Decompression Procedure to Treat Symptomatic Lumbar Spinal Stenosis,” was selected to receive one of three Resident/Fellow Travel awards. Coauthors are Jared Ramirez, Matthew Meroney, Ryan Skelly, Amir Jafari, Terri Vasilopoulos, Juan Mora, and Rene Przkora.

- Advertisement -

ASRA Pain Medicine is a professional society of more than 5,000 health care professionals devoted to advancing evidence-based practice of pain medicine across the pain continuum, from acute pain to chronic pain. Our mission is to advance the science and practice of regional anesthesia and pain medicine to improve patient outcomes through research, education, and advocacy. Our vision is to relieve the global burden of pain. We are committed to integrity, innovation, inclusiveness, service, compassion, and wellness. Learn more at www.asra.com. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.

Coordinated Care Supports Mother through Cancer and Pregnancy

Mega Doctor News By Kristen Zapata | UT Health San Antonio Two pink...
- Advertisement -